Congenital Heart Disease Clinical Trials in Madison, Wisconsin

4 studies are recruiting for congenital heart disease in Madison, Wisconsin right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. PDA for Kidneys Study

    The goal of this observational study is to gather more information on kidney oxygen levels in babies with a patent ductus arteriosus (PDA), and evaluate the relationships between kidney oxygen levels, PDA status and kidney injury. Researchers will do this by looking at ultrasound images of the hear…

    Stage
    Not phased
    Ages
    Up to 0
    Site
    Meriter Hospital, Inc., Madison, Wisconsin
    Run by
    University of Wisconsin, Madison
  2. Implementation of an Accessible Healthcare Model (ACHD STRONG): Comparing Nurse and Physician Lead Healthcare Transition Education in a RE-AIM Framework

    The study includes patients with congenital heart disease (CHD), as well as their support persons and their providers, who are preparing to make the transition from pediatric to adult care for their CHD. The purpose of this study is to improve the tools available to help find doctors as patients en…

    Stage
    Not phased
    Ages
    12 to 26
    Site
    University of Wisconsin, Madison, Wisconsin
    Run by
    University of Wisconsin, Madison
  3. ATrial Tachycardia PAcing Therapy in Congenital Heart

    Congenital heart disease (CHD) affects approximately 1% of newborns in the US, with 25% of those affected having critical conditions requiring open heart surgery within one year of birth. Surgical and medical advances have allowed many patients to live beyond their fourth and fifth decades of life.…

    Stage
    Not phased
    Ages
    Any age
    Site
    University of Wisconsin, Madison, Madison, Wisconsin
    Locations
    15 in total
    Run by
    Ian Law
  4. Fetal Electrophysiologic Abnormalities in High-Risk Pregnancies Associated With Fetal Demise

    Each year world-wide, 2.5 million fetuses die unexpectedly in the last half of pregnancy, 25,000 in the United States, making fetal demise ten-times more common than Sudden Infant Death Syndrome. This study will apply a novel type of non-invasive monitoring, called fetal magnetocardiography (fMCG) …

    Stage
    Not phased
    Ages
    18 and older
    Site
    University of Wisconsin - Madison, Madison, Wisconsin
    Locations
    2 in total
    Run by
    Medical College of Wisconsin

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.